Blood plasma showed no benefit in Covid-19 patients in trial
The findings, published in BMJ, could re-energize the debate over whether blood plasma is an effective treatment for the disease.
The findings, published in BMJ, could re-energize the debate over whether blood plasma is an effective treatment for the disease.
Check out the inaugural edition of Adam’s Biotech Scorecard, a new newsletter from @statnews.
Join STAT’s leading DC bureau as they take the stage with policymakers, patient advocates, and industry experts to discuss the biggest issues in health policy…
Could the FDA ban certain decaf coffees? Advocates want to strip out a chemical in the brew.
“This is not about, ‘O.K., let’s not use GLP-1s’ or anything. It’s just about, ‘let’s be careful when you’re doing procedures on these patients.’”
Krystal Tsosie, a life sciences professor at Arizona State, is a national leader on equity in genetics, genomics research, and Indigenous data sovereignty.
STATUS List 2024: Noted immunologist Drew Weissman is currently working on mRNA research for HIV, genital herpes, influenza, norovirus, and malaria.
Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Pick your favorites. Help us crown a champ!
Multiple sclerosis went from an untreatable disease to a known, druggable condition in less than 40 years. Now a study finds subtypes that may benefit from…
Covid wreaked havoc on the world. It also provided an unprecedented look at the human immune system.
The last 10 years have seen incredibly significant medical breakthroughs thanks to targeted and precision medicine. Hear from leaders and experts in the health care…